Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 185   

Articles published

PFE 32.89 +0.92 (2.88%)
price chart
Pfizer to buy Allergan in $160 billion deal
The acquisition, which would create the world's largest drugmaker and shift Pfizer's headquarters to Ireland, would also be the biggest-ever instance of a U.S.
Pfizer Inc, Allergan PLC confirm US$160-billion-mega-merger, but tax ...  Financial Post
EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And ...
Speaking to Benzinga, FBB Capital Partners' Mike Bailey said the Pfizer Inc. (NYSE: PFE) - Allergan PLC (NYSE: AGN) deal is a good cultural fit.
Pfizer Says No Merger Tax Help For Our Top Execs  Fortune
Equity Research Analysts at Suntrust Robinson Upped Pfizer Inc (NYSE:PFE) from ...
Suntrust Robinson raised the shares of Pfizer Inc (NYSE:PFE) from a Reduce rating to Neutral rating in analysts report sent to investors on Wednesday morning.
Pfizer Earns “Outperform” Rating from Cowen and Company (PFE)  WKRB News
Is it Time to Buy Pfizer? (NYSE:PFE)  Stock Markets Daily
Will The New Pfizer Be A Winner? SunTrust Analyst Thinks So, Upgrades Stock
Pfizer Inc. (NYSE: PFE) shares have been under pressure through the past month, and are down 4 percent since October 26. SunTrust Robinson Humphrey's John T. Boris upgraded the rating on the company from Reduce to Neutral, while raising the price ...
Pfizer Inc. (NYSE:PFE) - Large Cap Afternoon Report  Wall Street Observer
Pfizer Inc. (NYSE:PFE) Receives Neutral Rating From Suntrust Robinson Analysts  Risers & Fallers
Healthcare Major News- Pfizer Inc. (NYSE:PFE), Valeant Pharmaceuticals ...
Pfizer Inc. (PFE) reported recently top-line results of a Phase 3 study evaluating the efficacy and safety of LYRICA(pregabalin) Capsules CV in adults with chronic post-traumatic peripheral neuropathic pain.
Exclusive: Pfizer, Allergan CEOs agree on combined company roles - sources
Pfizer Inc and Allergan Inc chief executives have agreed on the roles they would assume in a combined company, removing one of the last hurdles to the largest ever healthcare merger, people familiar with the matter said.
Pfizer Heads for Fight With US on Tax-Saving Allergan Deal  Wall Street Journal
Pfizer Inc (PFE) Closes 2.82% Up on the Day for November 26
Dow Jones component Pfizer Inc ($PFE) saw its stock move 2.82% to $32.87, representing a per-share move of $0.9, on volume of 79.38 million shares for Thursday.
Pfizer Inc (PFE) Pops 2.82% for November 26
One of the S&P 500's big winners for Thursday November 26 was Pfizer Inc ($PFE) as the company's stock climbed 2.82% to $32.87 on volume of 79.38 million shares.
The Best Stocks to Own Now: Pfizer Inc. (NYSE:PFE), Net Element International ...
On the trading floor, shares of Pfizer Inc. (NYSE:PFE) gain 2.85% to close at $32.89. On Nov. 25, 2015 announced top-line results of a Phase 3 study evaluating the efficacy and safety of LYRICA� (pregabalin) Capsules CV in adults with chronic post ...
Pfizer's Lyrica shows no relief from post-traumatic nerve pain
(Reuters) - Pfizer Inc said its blockbuster pain drug, Lyrica, had failed to show benefit in patients suffering from a type of post-traumatic nerve pain, in a late-stage study.
Pfizer's LYRICA flunks late-stage trial in peripheral neuropathic pain  Seeking Alpha